Found: 3
Select item for more details and to access through your institution.
ISL1 predicts poor outcomes for patients with gastric cancer and drives tumor progression through binding to the ZEB1 promoter together with SETD7.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 2, p. 1, doi. 10.1038/s41419-018-1278-2
- By:
- Publication type:
- Article
The novel lncRNA p4516 acts as a prognostic biomarker promoting gastric cancer cell proliferation and metastasis.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 5375, doi. 10.2147/CMAR.S201793
- By:
- Publication type:
- Article
The influence of radiotherapy on the immune status of glioblastoma.
- Published in:
- Chinese Journal of Contemporary Neurology & Neurosurgery, 2020, v. 20, n. 2, p. 127, doi. 10.3969/j.issn.1672-6731.2020.02.009
- By:
- Publication type:
- Article